These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The transforming growth factor-beta family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl)retinamide. Ferrari N; Pfeffer U; Dell'Eva R; Ambrosini C; Noonan DM; Albini A Clin Cancer Res; 2005 Jun; 11(12):4610-9. PubMed ID: 15958647 [TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor alpha attenuates transforming growth factor-beta signaling in breast cancer cells independent from agonistic and antagonistic ligands. Stope MB; Popp SL; Knabbe C; Buck MB Breast Cancer Res Treat; 2010 Apr; 120(2):357-67. PubMed ID: 19370415 [TBL] [Abstract][Full Text] [Related]
5. Microglia-derived TGF-beta as an important regulator of glioblastoma invasion--an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor. Wesolowska A; Kwiatkowska A; Slomnicki L; Dembinski M; Master A; Sliwa M; Franciszkiewicz K; Chouaib S; Kaminska B Oncogene; 2008 Feb; 27(7):918-30. PubMed ID: 17684491 [TBL] [Abstract][Full Text] [Related]
6. Role of the EGFR ligand/receptor system in the secretion of angiogenic factors in mesenchymal stem cells. De Luca A; Gallo M; Aldinucci D; Ribatti D; Lamura L; D'Alessio A; De Filippi R; Pinto A; Normanno N J Cell Physiol; 2011 Aug; 226(8):2131-8. PubMed ID: 21520065 [TBL] [Abstract][Full Text] [Related]
7. Role of human cripto-1 in tumor angiogenesis. Bianco C; Strizzi L; Ebert A; Chang C; Rehman A; Normanno N; Guedez L; Salloum R; Ginsburg E; Sun Y; Khan N; Hirota M; Wallace-Jones B; Wechselberger C; Vonderhaar BK; Tosato G; Stetler-Stevenson WG; Sanicola M; Salomon DS J Natl Cancer Inst; 2005 Jan; 97(2):132-41. PubMed ID: 15657343 [TBL] [Abstract][Full Text] [Related]
8. Emergence of MCF-7 cells overexpressing a transfected epidermal growth factor receptor (EGFR) under estrogen-depleted conditions: evidence for a role of EGFR in breast cancer growth and progression. Miller DL; el-Ashry D; Cheville AL; Liu Y; McLeskey SW; Kern FG Cell Growth Differ; 1994 Dec; 5(12):1263-74. PubMed ID: 7696175 [TBL] [Abstract][Full Text] [Related]
10. Interaction with endothelial cells is a prerequisite for branching ductal-alveolar morphogenesis and hyperplasia of preneoplastic human breast epithelial cells: regulation by estrogen. Shekhar MP; Werdell J; Tait L Cancer Res; 2000 Jan; 60(2):439-49. PubMed ID: 10667599 [TBL] [Abstract][Full Text] [Related]
11. Serum derived from multiple trauma patients promotes the differentiation of endothelial progenitor cells in vitro: possible role of transforming growth factor-beta1 and vascular endothelial growth factor165. Henrich D; Hahn P; Wahl M; Wilhelm K; Dernbach E; Dimmeler S; Marzi I Shock; 2004 Jan; 21(1):13-6. PubMed ID: 14676678 [TBL] [Abstract][Full Text] [Related]
12. Nicotine regulates basic fibroblastic growth factor and transforming growth factor beta1 production in endothelial cells. Cucina A; Corvino V; Sapienza P; Borrelli V; Lucarelli M; Scarpa S; Strom R; Santoro-D'Angelo L; Cavallaro A Biochem Biophys Res Commun; 1999 Apr; 257(2):306-12. PubMed ID: 10198208 [TBL] [Abstract][Full Text] [Related]
13. Estrogen induction of smooth muscle differentiation of human prostatic stromal cells is mediated by transforming growth factor-beta. Hong JH; Song C; Shin Y; Kim H; Cho SP; Kim WJ; Ahn H J Urol; 2004 May; 171(5):1965-9. PubMed ID: 15076322 [TBL] [Abstract][Full Text] [Related]
14. Cross-talk between estradiol receptor and EGFR/IGF-IR signaling pathways in estrogen-responsive breast cancers: focus on the role and impact of proteoglycans. Skandalis SS; Afratis N; Smirlaki G; Nikitovic D; Theocharis AD; Tzanakakis GN; Karamanos NK Matrix Biol; 2014 Apr; 35():182-93. PubMed ID: 24063949 [TBL] [Abstract][Full Text] [Related]
15. Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis. de Jong JS; van Diest PJ; van der Valk P; Baak JP J Pathol; 1998 Jan; 184(1):53-7. PubMed ID: 9582527 [TBL] [Abstract][Full Text] [Related]
16. An anti-proliferative gene BTG1 regulates angiogenesis in vitro. Iwai K; Hirata K; Ishida T; Takeuchi S; Hirase T; Rikitake Y; Kojima Y; Inoue N; Kawashima S; Yokoyama M Biochem Biophys Res Commun; 2004 Apr; 316(3):628-35. PubMed ID: 15033446 [TBL] [Abstract][Full Text] [Related]
17. Expression pattern of fibroblast growth factors (FGFs), their receptors and antagonists in primary endothelial cells and vascular smooth muscle cells. Antoine M; Wirz W; Tag CG; Mavituna M; Emans N; Korff T; Stoldt V; Gressner AM; Kiefer P Growth Factors; 2005 Jun; 23(2):87-95. PubMed ID: 16019430 [TBL] [Abstract][Full Text] [Related]
18. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects. Tobin SW; Douville K; Benbow U; Brinckerhoff CE; Memoli VA; Arrick BA Oncogene; 2002 Jan; 21(1):108-18. PubMed ID: 11791181 [TBL] [Abstract][Full Text] [Related]
19. Crosstalk between EGFR and extranuclear steroid receptors. Migliaccio A; Castoria G; Di Domenico M; Ciociola A; Lombardi M; De Falco A; Nanayakkara M; Bottero D; De Stasio R; Varricchio L; Auricchio F Ann N Y Acad Sci; 2006 Nov; 1089():194-200. PubMed ID: 17261767 [TBL] [Abstract][Full Text] [Related]
20. Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. Morales DE; McGowan KA; Grant DS; Maheshwari S; Bhartiya D; Cid MC; Kleinman HK; Schnaper HW Circulation; 1995 Feb; 91(3):755-63. PubMed ID: 7530174 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]